The Potential of Polyphenols in Modulating the Cellular Senescence Process: Implications and Mechanism of Action
Pharmaceuticals · 22.01.2025 · 18 (2) · 138
DOI: 10.3390/ph18020138 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 22.01.2025. Verfasst von Larissa Della Vedova und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, University of Milan, Via Mangiagalli 25, 20133 Milan, Italy. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 145 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell'università e della ricerca, Distillerie Umberto Bonollo, Ministero dell’Università e della Ricerca PON “Ricerca e Innovazione”.
Abstract (Originalsprache)
Background
Cellular senescence is a biological process with a dual role in organismal health. While transient senescence supports tissue repair and acts as a tumor-suppressive mechanism, the chronic accumulation of senescent cells contributes to aging and the progression of age-related diseases. Senotherapeutics, including senolytics, which selectively eliminate senescent cells, and senomorphics, which modulate the senescence-associated secretory phenotype (SASP), have emerged as promising strategies for managing age-related pathologies. Among these, polyphenols, a diverse group of plant-derived bioactive compounds, have gained attention for their potential to modulate cellular senescence.
Methods
This review synthesizes evidence from in vitro, in vivo, and clinical studies on the senolytic and senomorphic activities of bioactive polyphenols, including resveratrol, kaempferol, apigenin, and fisetin. The analysis focuses on their molecular mechanisms of action and their impact on fundamental aging-related pathways.
Results
Polyphenols exhibit therapeutic versatility by activating SIRT1, inhibiting NF-κB, and modulating autophagy. These compounds demonstrate a dual role, promoting the survival of healthy cells while inducing apoptosis in senescent cells. Preclinical evidence indicates their capacity to reduce SASP-associated inflammation, restore tissue homeostasis, and attenuate cellular senescence in various models of aging.
Conclusions
Polyphenols represent a promising class of senotherapeutics for mitigating age-related diseases and promoting healthy lifespan extension. Further research should focus on clinical validation and the long-term effects of these compounds, paving the way for their development as therapeutic agents in geriatric medicine.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, University of Milan, Via Mangiagalli 25, 20133 Milan, Italy.
- Divisione Nutraceutica, Distillerie Umberto Bonollo S.p.A, Via G. Galilei 6, 35035 Mestrino, Italy.
ORCID-Profile: Larissa Della Vedova, Giovanna Baron, Giancarlo Aldini, Francesca Gado
Förderung
- Ministero dell'università e della ricerca
- Distillerie Umberto Bonollo
- Ministero dell’Università e della Ricerca PON “Ricerca e Innovazione”
Zitieren
APA
Della Vedova, L., Baron, G., Morazzoni, P., Aldini, G., & Gado, F. (2025). The Potential of Polyphenols in Modulating the Cellular Senescence Process: Implications and Mechanism of Action. Pharmaceuticals, 18(2), 138. https://doi.org/10.3390/ph18020138
Vancouver
Della Vedova L, Baron G, Morazzoni P, Aldini G, Gado F. The Potential of Polyphenols in Modulating the Cellular Senescence Process: Implications and Mechanism of Action. Pharmaceuticals. 2025;18(2):138. doi:10.3390/ph18020138
BibTeX
@article{DellaVedova2025,
author = {Della Vedova, Larissa and Baron, Giovanna and Morazzoni, Paolo and Aldini, Giancarlo and Gado, Francesca},
title = {The Potential of Polyphenols in Modulating the Cellular Senescence Process: Implications and Mechanism of Action},
journal = {Pharmaceuticals},
year = {2025},
volume = {18},
number = {2},
pages = {138},
doi = {10.3390/ph18020138}
}
EUVIMED